symbol,statement_type,period_end,line_item,value
SYNGENE.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,79381724.503713
SYNGENE.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.248068
SYNGENE.NS,income,2025-03-31 00:00:00,Normalized EBITDA,11136000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Total Unusual Items,320000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,320000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,4326000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,9425000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,EBITDA,11456000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,EBIT,7130000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Net Interest Income,-531000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Interest Expense,531000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Interest Income,
SYNGENE.NS,income,2025-03-31 00:00:00,Normalized Income,4721381724.503713
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Total Expenses,30313000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
SYNGENE.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
SYNGENE.NS,income,2025-03-31 00:00:00,Basic Average Shares,
SYNGENE.NS,income,2025-03-31 00:00:00,Diluted EPS,
SYNGENE.NS,income,2025-03-31 00:00:00,Basic EPS,
SYNGENE.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Minority Interests,
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,4962000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Tax Provision,1637000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Pretax Income,6599000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,718000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Special Income Charges,320000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Other Special Charges,
SYNGENE.NS,income,2025-03-31 00:00:00,Write Off,
SYNGENE.NS,income,2025-03-31 00:00:00,Restructuring And Mergern Acquisition,
SYNGENE.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-531000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,531000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
SYNGENE.NS,income,2025-03-31 00:00:00,Operating Income,6111000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Operating Expense,20888000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Other Operating Expenses,6723000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,4326000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Amortization,
SYNGENE.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,4326000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Selling General And Administration,
SYNGENE.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
SYNGENE.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
SYNGENE.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
SYNGENE.NS,income,2025-03-31 00:00:00,Gross Profit,26999000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Cost Of Revenue,9425000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Total Revenue,36424000000.0
SYNGENE.NS,income,2025-03-31 00:00:00,Operating Revenue,36424000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-19811211.340206
SYNGENE.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.178479
SYNGENE.NS,income,2024-03-31 00:00:00,Normalized EBITDA,11050000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Total Unusual Items,-111000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-111000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,4259000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,9302000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,EBITDA,10939000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,EBIT,6680000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Interest Income,-314000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Interest Expense,472000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Interest Income,158000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Normalized Income,5191188788.659794
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Total Expenses,28443000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,55000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Diluted Average Shares,401891253.0
SYNGENE.NS,income,2024-03-31 00:00:00,Basic Average Shares,401258851.0
SYNGENE.NS,income,2024-03-31 00:00:00,Diluted EPS,12.69
SYNGENE.NS,income,2024-03-31 00:00:00,Basic EPS,12.71
SYNGENE.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Minority Interests,0.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,5100000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Tax Provision,1108000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Pretax Income,6208000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,748000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Special Income Charges,-111000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Other Special Charges,136000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Write Off,6000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Restructuring And Mergern Acquisition,111000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-314000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,472000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,158000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Operating Income,6443000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Operating Expense,19141000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Other Operating Expenses,5995000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,4259000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Amortization,79000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,4259000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Selling General And Administration,1697000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,203000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,General And Administrative Expense,1494000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,55000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Gross Profit,25584000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Cost Of Revenue,9302000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Total Revenue,34886000000.0
SYNGENE.NS,income,2024-03-31 00:00:00,Operating Revenue,34886000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,4578000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.218
SYNGENE.NS,income,2023-03-31 00:00:00,Normalized EBITDA,9925000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Total Unusual Items,21000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,21000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,3665000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,8602000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,EBITDA,9946000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,EBIT,6281000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Interest Income,258000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Interest Expense,345000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Interest Income,603000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Normalized Income,4627578000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Total Expenses,24620000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,44000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Diluted Average Shares,403620257.0
SYNGENE.NS,income,2023-03-31 00:00:00,Basic Average Shares,400658428.0
SYNGENE.NS,income,2023-03-31 00:00:00,Diluted EPS,11.51
SYNGENE.NS,income,2023-03-31 00:00:00,Basic EPS,11.59
SYNGENE.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Minority Interests,0.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,4644000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Tax Provision,1292000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Pretax Income,5936000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,709000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Special Income Charges,-85000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Other Special Charges,75000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Write Off,10000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Restructuring And Mergern Acquisition,
SYNGENE.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,258000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,345000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,603000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Operating Income,6182000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Operating Expense,16018000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Other Operating Expenses,3727000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,3665000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Amortization,58000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,3607000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Selling General And Administration,1236000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,185000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,General And Administrative Expense,1051000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,44000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Gross Profit,22200000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Cost Of Revenue,8602000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Total Revenue,30802000000.0
SYNGENE.NS,income,2023-03-31 00:00:00,Operating Revenue,30802000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-49776000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.183
SYNGENE.NS,income,2022-03-31 00:00:00,Normalized EBITDA,8388000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Total Unusual Items,-272000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-272000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,3097000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,7490000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,EBITDA,8116000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,EBIT,5019000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Interest Income,290000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Interest Expense,175000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Interest Income,465000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Normalized Income,4180224000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Total Expenses,20723000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,48000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Diluted Average Shares,402897208.0
SYNGENE.NS,income,2022-03-31 00:00:00,Basic Average Shares,398148760.0
SYNGENE.NS,income,2022-03-31 00:00:00,Diluted EPS,9.82
SYNGENE.NS,income,2022-03-31 00:00:00,Basic EPS,9.94
SYNGENE.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Minority Interests,0.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,3958000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Tax Provision,886000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Pretax Income,4844000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,528000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Special Income Charges,-335000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Other Special Charges,327000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Write Off,8000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Restructuring And Mergern Acquisition,
SYNGENE.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,290000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,175000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,465000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Operating Income,4344000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Operating Expense,13233000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Other Operating Expenses,2922000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,3097000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Amortization,67000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,3030000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Selling General And Administration,910000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,117000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,General And Administrative Expense,793000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,48000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Gross Profit,17577000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Cost Of Revenue,7490000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Total Revenue,25067000000.0
SYNGENE.NS,income,2022-03-31 00:00:00,Operating Revenue,25067000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
SYNGENE.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
SYNGENE.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
SYNGENE.NS,income,2021-03-31 00:00:00,Total Unusual Items,
SYNGENE.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
SYNGENE.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
SYNGENE.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
SYNGENE.NS,income,2021-03-31 00:00:00,EBITDA,
SYNGENE.NS,income,2021-03-31 00:00:00,EBIT,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Interest Income,
SYNGENE.NS,income,2021-03-31 00:00:00,Interest Expense,
SYNGENE.NS,income,2021-03-31 00:00:00,Interest Income,623000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Normalized Income,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
SYNGENE.NS,income,2021-03-31 00:00:00,Total Expenses,
SYNGENE.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,38000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Diluted Average Shares,400668505.0
SYNGENE.NS,income,2021-03-31 00:00:00,Basic Average Shares,397725075.0
SYNGENE.NS,income,2021-03-31 00:00:00,Diluted EPS,10.11
SYNGENE.NS,income,2021-03-31 00:00:00,Basic EPS,10.18
SYNGENE.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
SYNGENE.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income,
SYNGENE.NS,income,2021-03-31 00:00:00,Minority Interests,0.0
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
SYNGENE.NS,income,2021-03-31 00:00:00,Tax Provision,
SYNGENE.NS,income,2021-03-31 00:00:00,Pretax Income,
SYNGENE.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
SYNGENE.NS,income,2021-03-31 00:00:00,Special Income Charges,
SYNGENE.NS,income,2021-03-31 00:00:00,Other Special Charges,-291000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Write Off,16000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Restructuring And Mergern Acquisition,
SYNGENE.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
SYNGENE.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
SYNGENE.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,623000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Operating Income,
SYNGENE.NS,income,2021-03-31 00:00:00,Operating Expense,
SYNGENE.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
SYNGENE.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
SYNGENE.NS,income,2021-03-31 00:00:00,Amortization,73000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
SYNGENE.NS,income,2021-03-31 00:00:00,Selling General And Administration,660000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,64000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,General And Administrative Expense,596000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,38000000.0
SYNGENE.NS,income,2021-03-31 00:00:00,Gross Profit,
SYNGENE.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
SYNGENE.NS,income,2021-03-31 00:00:00,Total Revenue,
SYNGENE.NS,income,2021-03-31 00:00:00,Operating Revenue,
